Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 5Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 5OTHER 2NETWORK 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Genitourinary 6

Conditions

Non-Muscle Invasive Bladder Neoplasms 5Urinary Bladder Neoplasms 3Side Effect of Drug 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Carcinoma in Situ 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Interventional × BCG Vaccine × 1 year × Clear all
NCT06833073 2026-05-28

INTerpath-011

Merck Sharp & Dohme LLC

Phase 2 Recruiting
308 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT05538663 2026-05-05

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
870 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03711032 2026-05-01

MK-3475-676

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
1,397 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT03528694 2026-04-14

POTOMAC

AstraZeneca

Phase 3 Active not recruiting
1,018 enrolled 1 FDA
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05037279 2026-03-20

EVER

Verity Pharmaceuticals Inc.

Phase 3 Recruiting
540 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT04701151 2026-03-03

NORTH-REG Dwell-Time Study

Aarhus University Hospital

Phase 4 Active not recruiting
314 enrolled

Side Effect of Drug

NCT04165317 2026-01-22

CREST

Pfizer

Phase 3 Active not recruiting
1,068 enrolled 20 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07064863 2025-07-17

BCG-TIME

Queen's University

Phase 1/2 Not yet recruiting
31 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡